Study links Tramadol use to increased Hip fracture risk
Opioid treatment for chronic pain is a known risk factor for falls and/or fractures in elderly patients. Tramadol has a higher risk of fractures than some other opioid analgesics used to treat moderate-to-severe pain.
The use of pain medication tramadol was linked with a higher risk of hip fractures compared with the use of other pain medications in an analysis of a patient database from the United Kingdom.
Tramadol is used to help relieve moderate to moderately severe pain. It is similar to opioid (narcotic) analgesics and works in the brain to change feeling and response of the body to pain.
The analysis, which is published in the Journal of Bone and Mineral Research, compared tramadol use with codeine, naproxen, ibuprofen, celecoxib, and etoricoxib use among adults aged 50 years or older.
During a one-year follow-up, 518 hip fractures occurred among 146,956 patients taking tramadol, corresponding to approximately one additional new hip fracture per 1000 person-years relative to taking codeine (3.7 vs. 2.9, respectively). Likewise, up to 1.5 additional new fractures per 1000 person-years occurred with tramadol than with naproxen, ibuprofen, celecoxib, and etoricoxib.
"Considering the significant impact of hip fracture on morbidity, mortality, and healthcare costs, our results point to the need to consider tramadol's associated risk of fracture in clinical practice and treatment guidelines," said corresponding author Guanghua Lei, MD, PhD, of Xiangya Hospital, Central South University.
Opioids are an important pharmaceutical treatment for moderate-to-severe pain. Withdrawal of opioid use without having effective replacement therapies available could lead to worse patient outcomes and create costs for the health system through inadequately controlled pain. An alternative approach to the withdrawal of treatment could be to modify the medication used, thus avoiding opioids that are associated with a high risk of falls and fractures.
For more details click on the link: http://dx.doi.org/10.1002/jbmr.3935
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.